Thomson's Research
Human embryonic stem cells can divide without limit, and yet maintain the potential to make all the cells of the body. This remarkable potential makes them useful for basic research on the function of the human body, for drug discovery and testing, and as a source of cells and tissues for transplantation medicine. In 1998, Thomson’s Lab was the first to report the successful isolation of human embryonic stem cells. On November 6, 1998, Science published this research in an article titled "Embryonic Stem Cell Lines Derived from Human Blastocysts", results which Science later featured in its “Scientific Breakthrough of the Year” article, 1999.
In spite of their great medical potential, however, human embryonic stem cells generated enormous controversy because their derivation involved the destruction of a human embryo. In 2007, Thomson’s group (contemporaneously with Dr. Shinya Yamanaka) reported a method for converting human skin cells into cells that very closely resemble human embryonic stem cells. Published in Science in late 2007 in an article titled "Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells", the results garnered international attention for potentially ending the ethical controversy surrounding human embryonic stem cell research. Science later featured induced pluripotent stem cells in its “Scientific Breakthrough of the Year” article, 2008.
Read more about this topic: James Thomson (cell Biologist)
Famous quotes containing the words thomson and/or research:
“The mighty river flowing dark and deep,
With ebb and flood from the remote sea-tides
Vague-sounding through the City’s sleepless sleep,
Is named the River of the Suicides;”
—James Thomson (1834–1882)
“The great question that has never been answered, and which I have not yet been able to answer, despite my thirty years of research into the feminine soul, is “What does a woman want?””
—Sigmund Freud (1856–1939)